Viewing Study NCT03125902


Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2026-01-25 @ 4:32 AM
Study NCT ID: NCT03125902
Status: COMPLETED
Last Update Posted: 2024-03-26
First Post: 2017-04-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)
Sponsor: Hoffmann-La Roche
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Triple-Negative Breast Cancer View
Keywords: